| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A novel FFA1 agonist, CPU025, improves glucose-lipid metabolism and alleviates fatty liver in obese-diabetic (ob/ob) mice
|
Li, Zheng
|
|
|
153 |
C |
p.
|
article
|
| 2 |
Clinical efficacy and safety of aidi injection combination with vinorelbine and cisplatin for advanced non–small-cell lung carcinoma: A systematic review and meta-analysis of 54 randomized controlled trials
|
Xiao, Zheng
|
|
|
153 |
C |
p.
|
article
|
| 3 |
Corrigendum to “Disocin prevents postmenopausal atherosclerosis in ovariectomized LDLR-/mice through a PGC-1α/ERα pathway leading to promotion of autophagy and inhibition of oxidative stress, inflammation and apoptosis” [Pharmacol. Res. 148 (2019) 104414]
|
Yang, Qining
|
|
|
153 |
C |
p.
|
article
|
| 4 |
Corrigendum to “Nitidine chloride exerts anti-inflammatory action by targeting topoisomerase I and enhancing IL-10 production” [Pharmacol. Res. 148 (2019) 104368]
|
Yang, Niao
|
|
|
153 |
C |
p.
|
article
|
| 5 |
Corrigendum to “The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors” [Pharmacol. Res. 147 (2019) 104392]
|
Bechman, Katie
|
|
|
153 |
C |
p.
|
article
|
| 6 |
Editorial Board
|
|
|
|
153 |
C |
p.
|
article
|
| 7 |
Effect of Lactobacillusplantarum containing probiotics on blood pressure: A systematic review and meta-analysis
|
Lewis-Mikhael, Anne-Mary
|
|
|
153 |
C |
p.
|
article
|
| 8 |
Exploring and characterizing a novel combination of paeoniflorin and talatizidine for the treatment of rheumatoid arthritis
|
Mao, Xia
|
|
|
153 |
C |
p.
|
article
|
| 9 |
Gut microbiota and neuroinflammation in pathogenesis of hypertension: A potential role for hydrogen sulfide
|
Donertas Ayaz, Basak
|
|
|
153 |
C |
p.
|
article
|
| 10 |
Hypericin attenuates nonalcoholic fatty liver disease and abnormal lipid metabolism via the PKA-mediated AMPK signaling pathway in vitro and in vivo
|
Liang, Chen
|
|
|
153 |
C |
p.
|
article
|
| 11 |
Incretins and microRNAs: Interactions and physiological relevance
|
Radbakhsh, Shabnam
|
|
|
153 |
C |
p.
|
article
|
| 12 |
LYW-6, a novel cryptotanshinone derived STAT3 targeting inhibitor, suppresses colorectal cancer growth and metastasis
|
Wang, Huan
|
|
|
153 |
C |
p.
|
article
|
| 13 |
Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: New therapeutic approaches for the treatment of atherogenic dyslipidemia
|
Ruscica, Massimiliano
|
|
|
153 |
C |
p.
|
article
|
| 14 |
Pharmacological potential of the combination of Salvia miltiorrhiza (Danshen) and Carthamus tinctorius (Honghua) for diabetes mellitus and its cardiovascular complications
|
Orgah, John O.
|
|
|
153 |
C |
p.
|
article
|
| 15 |
Piceatannol: A natural stilbene for the prevention and treatment of cancer
|
Banik, Kishore
|
|
|
153 |
C |
p.
|
article
|
| 16 |
Probing biological mechanisms with chemical tools
|
Kang, Congbao
|
|
|
153 |
C |
p.
|
article
|
| 17 |
Role of heterogeneous regulatory T cells in the tumor microenvironment
|
Wei, Ting
|
|
|
153 |
C |
p.
|
article
|
| 18 |
SERCA and P-glycoprotein inhibition and ATP depletion are necessary for celastrol-induced autophagic cell death and collateral sensitivity in multidrug-resistant tumor cells
|
Xu, Su-Wei
|
|
|
153 |
C |
p.
|
article
|
| 19 |
Tectorigenin attenuates diabetic nephropathy by improving vascular endothelium dysfunction through activating AdipoR1/2 pathway
|
Yang, Shu
|
|
|
153 |
C |
p.
|
article
|
| 20 |
The pivotal role of nuclear factor erythroid 2-related factor 2 in diabetes-induced endothelial dysfunction
|
Karan, Amin
|
|
|
153 |
C |
p.
|
article
|
| 21 |
The Rho guanine nucleotide exchange factor P-Rex1 as a potential drug target for cancer metastasis and inflammatory diseases
|
Ye, Richard D.
|
|
|
153 |
C |
p.
|
article
|
| 22 |
The role of hepcidin and iron homeostasis in atherosclerosis
|
Wunderer, Florian
|
|
|
153 |
C |
p.
|
article
|
| 23 |
Translation of pharmacogenomic drug labels into the clinic. Current problems
|
Ingelman-Sundberg, Magnus
|
|
|
153 |
C |
p.
|
article
|
| 24 |
Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer
|
Deepak, K.G.K.
|
|
|
153 |
C |
p.
|
article
|
| 25 |
Unveiling the guidance heterogeneity for genome-informed drug treatment interventions among regulatory bodies and research consortia
|
Koutsilieri, Stefania
|
|
|
153 |
C |
p.
|
article
|
| 26 |
Urolithin B, a gut microbiota metabolite, protects against myocardial ischemia/reperfusion injury via p62/Keap1/Nrf2 signaling pathway
|
Zheng, Dechong
|
|
|
153 |
C |
p.
|
article
|
Journal description